Clinical Trial Update: Advancing Reperfusion Therapy for Ischemic Stroke (ARTS): Tenecteplase in Medium Vessel Occlusion (MeVO) for Acute Ischemic Stroke [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update (ARTS) is evaluating tenecteplase for reperfusion in acute ischemic stroke due to medium vessel occlusions and is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• TNK-tPA (tenecteplase) (tenecteplase)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Stroke, Ischemic, Medium Vessel Occlusions | Phase 3 | Status: RECRUITING